Literature DB >> 8406004

Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element.

M K Shin1, M E Koshland.   

Abstract

In a primary immune response, a signal from interleukin-2 (IL-2) activates transcription of the gene encoding the pentamer IgM joining component, the J chain. Recently, a bifunctional control element (JB) in the J-chain promoter has been identified. This finding was pursued in the present study by purifying and characterizing the nuclear protein (NF-JB) that mediates the positive regulatory activity of the JB element. The analyses revealed that NF-JB is identical to the Ets-related B-cell- and macrophage-specific transcriptional factor, PU.1, despite the fact that the JB site lacks the GGA core reported to be essential for binding by members of the Ets oncoprotein family. The two factors were found to be indistinguishable with respect to their DNA-binding characteristics, size, and peptide structure. Moreover, in transient transfection assays, PU.1 alone activated reporter constructs containing the JB cis-element, and the activation was shown to be dependent on a glutamine-rich sequence in the amino-terminal portion of PU.1. Finally, a dominant negative mutant of PU.1 was capable of suppressing the transcriptional activity of a 1.2-kb J-chain promoter sequence. These results establish an important role for PU.1 in the regulation of immunoglobulin J-chain gene expression and provide new insights into the function(s) of the Ets transcription factors in lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406004     DOI: 10.1101/gad.7.10.2006

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  33 in total

1.  Mutants of ETS domain PU.1 and GGAA/T recognition: free energies and kinetics.

Authors:  F Pio; N Assa-Munt; J Yguerabide; R A Maki
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

3.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.

Authors:  M T Voso; T C Burn; G Wulf; B Lim; G Leone; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Authors:  M S Petrovick; S W Hiebert; A D Friedman; C J Hetherington; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.

Authors:  G H Su; H M Chen; N Muthusamy; L A Garrett-Sinha; D Baunoch; D G Tenen; M C Simon
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.

Authors:  B Erman; R Sen
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

8.  Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor.

Authors:  C Perez; E Coeffier; F Moreau-Gachelin; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.

Authors:  Kevin S Choe; Olga Ujhelly; Sandeep N Wontakal; Arthur I Skoultchi
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

10.  Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.